Inyx, Inc. Stock price

Equities

IYXI

US4618681013

Pharmaceuticals

Market Closed - OTC Markets 09:31:11 2024-01-12 am EST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Inyx, Inc. -.--% -.--%
Sales 2004 15.7M Sales 2005 49.56M Capitalization 75.26M
Net income 2004 -16M Net income 2005 -31M EV / Sales 2004 3.37 x
Net Debt 2004 14.45 Net Debt 2005 98.53 EV / Sales 2005 1.52 x
P/E ratio 2004
-2.67 x
P/E ratio 2005
-2.41 x
Employees 572
Yield 2004 *
-
Yield 2005
-
Free-Float 98.86%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.01
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.20
More quotes
Inyx, Inc. is a provider of specialty pharmaceutical products and technologies. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.
More about the company
  1. Stock
  2. Equities
  3. Stock Inyx, Inc. - OTC Markets